You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK — Genetic testing firm Prenetics said on Friday that it has acquired Oxsed, a University of Oxford spinout that was founded to develop and launch a rapid test for SARS-CoV-2.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.
The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.
A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.
In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.